Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
|Articles|January 1, 2016
- Pharmaceutical Technology-01-02-2016
- Volume 40
- Issue 1
Plastic Union Tri-Clamp
The BioClamp Plastic Tri-Clamp, from BioPure Technology, part of the Watson-Marlow Fluid Technology Group, is a patented plastic union tri-clamp meant to reduce distortion on polymeric fittings when subjected to heat.
The BioClamp Plastic Tri-Clamp, from BioPure Technology, part of the Watson-Marlow Fluid Technology Group, is a patented plastic union tri-clamp meant to reduce distortion on polymeric fittings when subjected to heat. The clamp is molded from reinforced Nylon 66 USP Class VI, FDA, includes a tamper-evident feature, and is suitable for sterilization by autoclave and gamma irradiation. The instrument is manufactured and packed in an ISO Class 7 cleanroom and has lot numbers molded in for full traceability.
Articles in this issue
almost 11 years ago
Parenteral Packaging: 2021almost 11 years ago
Politics and Pricing Will Challenge Manufacturers in 2016almost 11 years ago
Managing Market Expansion’s Effect on Proceduresalmost 11 years ago
Phase-Appropriate Formulation and Process Designalmost 11 years ago
Reducing the Documentation Burden in Process Validationalmost 11 years ago
Reducing the Environmental Impact of Manufacturingalmost 11 years ago
Cleaning Limits—Why the 10-ppm Criterion should be Abandonedalmost 11 years ago
Using Deterministic Container Closure Integrity Testingalmost 11 years ago
The Market Consolidates for Better Servicealmost 11 years ago
Global Drug DirectionsRelated to this article
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
CPHI Milan: Packaging and Delivery Decisions Must Reflect Real-World Care
3
Manufacturing Intelligence: Organoids, Organ-on-a-Chip, and the Trust Gap
4
Complying with International Pharmacopoeias
5